# Effects of IL-1 Beta on the HPA-axis in Obese Persons

> **NCT02227420** · PHASE3 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 76 (actual)

## Conditions studied

- Metabolic Syndrome
- Hypersecretion; Cortisol

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT02227420
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-07
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2016-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02227420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02227420, "Effects of IL-1 Beta on the HPA-axis in Obese Persons". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02227420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*